ArticlePediatric research2026
Beyond numbers: rethinking human milk fortification in preterm nutrition.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As neonatal care continues to evolve, there is growing recognition of the need for individualized, functionally targeted nutrition in very preterm infants (VPIs). While human milk remains the gold standard, it frequently fails to meet the metabolic requirements of this high-risk group, requiring the adoption of fortification strategies. In this context, the study by Rasmussen et al., published in Pediatric Research, offers important insights into the metabolic implications of fortifying human milk with bovine colostrum (BC). The observed elevations in plasma concentrations of amino acids such as arginine, glutamine, and tyrosine suggest that BC may serve as a fortifier with potential clinical value. However, the disconnection between enhanced biochemical profiles and clear clinical benefit persists. Nutrient utilization depends not only on intake but also on inflammation, illness, organ immaturity, and individual metabolic variations. Infants' anthropometrics, mainly head circumference and length, remain essential reference values, mirroring brain and lean mass development. A shift toward precision strategies incorporating biomarkers and long-term developmental follow-up is needed. This approach might hopefully be translated into sustained clinical benefit for VPIs. IMPACT: This commentary emphasizes the importance of evaluating neonatal nutrition through both surrogate biomarkers and functional clinical outcomes to better capture physiological relevance. It highlights the limitations of relying exclusively on compositional or biochemical analyses when assessing nutritional adequacy in preterm infants. The article contextualizes the findings of Rasmussen et al. within the metabolic complexity characteristic of preterm physiology. It underscores the role of clinical heterogeneity and variable nutrient utilization in shaping metabolic responses. The commentary advocates for integrated, technology-supported strategies to enable individualized, real-time precision nutrition in neonatal care.
Indexed as
Identifiers
41826705What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.